Aaron Osborne is a Drug Developer and Therapy Area Head of Ophthalmology at Genentech, bringing over 20 years of expertise in industry and clinical practice to the field. In their current role, they focus on advancing innovative treatments aimed at improving patient outcomes through strategic medical leadership. Aaron has held prominent positions in global biopharmaceutical organizations, including Chief Medical Officer roles at Nanoscope Therapeutics and Adverum Biotechnologies. With a foundation in clinical practice as an Eye Surgeon within the British NHS, Aaron is dedicated to addressing unmet medical needs through collaboration and team-building. They are currently pursuing a Bachelor of Medicine Bachelor of Surgery (MBBS) at UCL.
This person is not in any teams
This person is not in any offices